You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Aug 1, 2025

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
Joseph V Panetta1, Iavor Veltchev1, Robert A Price1
1Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Quality assurance (QA) passing rates for intensity modulated radiation therapy (IMRT) plans correlate with dose gradient. However, the specific QA slice impacts results, and dose gradient doesn't reliably predict passing rates.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: